Cempra (CEMP) kicked off its morning with positive news that sent its stock soaring ahead of market's open. 

The Chapel Hill, N.C.-based biotech announced top line results from a phase three clinical trial of its fusidic acid, which can be used to treat skin infections Friday morning. The company's stock was up 46% ahead of the opening bell on the news, hitting $4.65 per share. This, though, was not enough for shares to regain the loss of 82% of their value experienced in the past year. 

Incyte (INCY) , meanwhile, was up 5% pre-market thanks to news that it will join the S&P 500, replacing Spectra Energy Corp. (SE) . Incyte shares hit $128.10 apiece ahead of the opening bell Friday. The company has seen a 63% boost to share price over the past year. 

Achillion Pharmaceuticals (ACHN) , meanwhile, was plummeting after reporting a loss for its fourth quarter after market's close Thursday. The company reported a loss of $4.4 million, or 3 cents per share. These results, though, beat the street's expectations of a loss of 18 cents per share. Investors, though, were still dumping the stock Friday ahead of market's open. Achillion shares fell 5.66% Friday, hitting $4 per share. This year, the company has lost 36% of its market value. 

Inovio (INO) , meanwhile, continued to climb ahead of market's open Friday. The company had a positive day Thursday, finishing up 4.5% after reporting positive clinical data on its Zika vaccine. Inovio continued to climb Friday ahead of the opening bell. Shares were up 2.03% ahead of market's open, hitting $7.04 apiece. 

More from Stocks

Ford, GM Leap on Report China Preparing to Slash US Import Tariffs

Ford, GM Leap on Report China Preparing to Slash US Import Tariffs

McDonald's Limited Risk Is Appealing to Conservative Investors

McDonald's Limited Risk Is Appealing to Conservative Investors

Pfizer Slips After JPMorgan Downgrade on Patent Cycle Concerns

Pfizer Slips After JPMorgan Downgrade on Patent Cycle Concerns

Verizon to Take Massive Charges From Employee Buyouts, Weakness at Oath

Verizon to Take Massive Charges From Employee Buyouts, Weakness at Oath

DSW Leaps as Shoe Retailer Posts Strong Earnings, Guidance

DSW Leaps as Shoe Retailer Posts Strong Earnings, Guidance